Skip to content

On-X Aortic Heart Valve with Standard Sewing Ring and Extended Holder ONXAE-21Recalls & reported problems

On-X Life Technologies, Inc. · The On-X® Prosthetic Heart Valve is a bileaflet mechanical heart valve, which consists of an orifice housing and two leaflets. The orifice inflow area has a flared inlet designed to reduce flow turbulence, and the outflow rim consists of leaflet guards designed to protect the leaflets while in the closed position. The leaflets rotate around tabs located within the inner circumference of the orifice ring. In the closed position, each leaflet forms a nominal angle of 40º relative to the plane of the orifice. In the open position, the plane of each leaflet forms a nominal angle of 90deg relative to the plane of the orifice. The leaflets have a travel arc of 50deg to the closed position. The orifice, or housing, is composed of a graphite substrate coated with On-X® Carbon, a pure unalloyed form of pyrolytic carbon. The leaflets consist of On-X® Carbon deposited on a graphite substrate, which is impregnated with 10 weight% tungsten to provide radiopacity. The sewing cuff is constructed of polytetrafluoroethylene (PTFE) fabric mounted on the orifice using titanium retaining rings and 5-0 suture material. This form of sewing cuff attachment to the orifice allows for rotation of the sewing cuff in situ during implantation. Orientation reference marks are provided on the sewing cuff for valve orientation. The On-X® Prosthetic Heart Valve is available in 3 aortic and 2 mitral sewing cuff configurations. Aortic configurations are available in sizes 19, 21, 23, 25, and 27/29 mm. The standard mitral cuff is available in sizes 23, 25, 27/29 and 31/33, while the Conform-X® mitral cuff is available in size 25/33 only. Further detail for the On-X prosthetic heart valve is described in the Summary of Safety and Effectiveness documents for the On-X heart valves: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037b.pdf (aortic), and http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037S001b.pdf (mitral). · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
1
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00851788001396), received between Oct 3, 2016 and Mar 9, 2026 — classified as 1 death, 3 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

4 other recalls cover devices cleared under the same FDA submission (P000037); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Insufficient Device Problem Information1

Patient problems

  • Insufficient Information2
  • Death1
  • No Clinical Signs, Symptoms or Conditions1
  • No Information1
  • Stroke/CVA1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 9, 2026Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE MEDWATCH FORM RECEIVED VIA EMAIL FROM THE FDA MEDICAL DEVICE REPORTING TEAM ON 02/11/2026, ¿DESCRIBE THE EVENT OR PROBLEM: AFTER SECURING THE COR-KNOTS, THE SURGEON ATTEMPTED TO CUT OUT THE VALVE HOLDER, HOWEVER IT DID NOT DISLODGE. THE SUTURE OF THE VALVE HOLDER WAS CUT AND HANDLE WAS REMOVED, BUT VALVE WOULD STILL NOT COME OUT. THERE WAS CONCERN THE VALVE HAD BECOME DAMAGED WHEN TRYING TO REMOVE THE HOLDER. A STERNOTOMY WAS PERFORMED AND THE VALVE WAS REMOVED AND REPLACED WITH A DIFFERENT VALVE. WHAT WAS THE ORIGINAL INTENDED PROCEDURE? : MINIMALLY INVASIVE AORTIC VALVE REPLACEMENT, USING RIGHT MINI THORACOTOMY APPROACH WHAT PROBLEM DID THE USER HAVE: DEVICE FAILED (E.G. BROKE, COULDN'T GET IT TO WORK OR STOPPED WORKING)¿. FDA MEDWATCH FORM 3500A MEDSUN REPORT NUMBER: (B)(4).

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 24544121 ↗
  • DeathSep 16, 2022Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    ON SEPTEMBER 1, 2022 THE FDA FORWARDED A MEDWATCH REPORT (B)(4) WHICH WAS SUBMITTED BY THE USER FACILITY IDENTIFYING AN ARTIVION PRODUCT. ACCORDING TO THE REPORT, "PATIENT HAD AN AORTIC VALVE REPLACEMENT WITH USAGE OF A MECHANICAL VALVE. SURGERY WITHOUT COMPLICATIONS. PATIENT DIED SEVERAL DAYS LATER AT HOME." THE PROCEDURE WAS REPORTED AS "AORTIC VALVE REPLACEMENT WITH LEFT ATRIAL APPENDAGE LIGATION." ADDITIONAL INFORMATION REPORTED STATES: "INR ONLY GOT AS HIGH AS 1.2 BEFORE PATIENT DIED." THE PATIENT WAS IDENTIFIED AS A 47-YEAR OLD FEMALE, WEIGHING 221 LBS., WITH THE FOLLOWING PRE-EXISTING CONDITIONS: "DIABETES; HYPERTENSION; MORBIDLY OBESE." ADDITIONAL INFORMATION WAS RECEIVED ON 9/7/2022: "THE PATIENT'S NATIVE VALVE WAS REPLACED WITH AN ONX VALVE. THE CAUSE OF DEATH IS UNKNOWN AND THE FAMILY REFUSED AN AUTOPSY. THE RECORDS [MEDICAL RECORDS, OPERATIVE NOTES, RE-OPERATIVE NOTES] ARE NOT BEING RELEASED."

    Patient problems: Insufficient Information

    MAUDE report 15438793 ↗
  • InjuryJun 2, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, A (B)(6) FEMALE THAT HAD AN ON-X AORTIC VALVE IMPLANTED ON (B)(6) 2019 SUFFERED A STROKE IN (B)(6) 2022 AND INR WAS INCREASED TO 3.8. HOME MONITORING WAS SUGGESTED. PATIENT IS ALSO DOING PHYSICAL AND SPEECH THERAPY. INR RECORDS SHOWED RANGE OF LOW (1.2 IN MARCH 2022) TO AN AVERAGE OF ABOUT 2.1.

    Patient problems: Stroke/CVA

    MAUDE report 14574916 ↗
  • InjuryOct 3, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IMPLANT RECOVERY CARDS RECEIVED INDICATED THAT PATIENT RECEIVED ONXAE-23 ON (B)(6) 2011 WHICH REQUIRED INTERVENTION/EXPLANT ON (B)(6) 2014 AND REPLACEMENT WITH ONXAE-21 FOR UNSPECIFIED REASON. ADDITIONAL INFORMATION RECEIVED VIA PHONE CONVERSATION ON (B)(6) 2016 WITH THE NURSE INDICATED THAT THE PATIENT WAS NOW DECEASED AND NO INFORMATION WOULD BE RELEASED FOR THE PATIENT.

    Patient problems: Death; No Information

    MAUDE report 5995223 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P000037. One submission often covers many models, so check the product and lot details in each record.

  • Z-2133-2026 · Feb 1, 2026 · Open, Classified
    On-X Mitral Heart Valve with Conform-X Sewing Ring, Model: ONXMC-25/33
  • Z-1073-2019 · Jan 17, 2019 · Terminated
    On-X Aortic Heart Valve with Anatomic Sewing Ring Product Usage: The On-X Prosthetic Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native
  • Z-2715-2017 · Jun 12, 2015 · Terminated
    On-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic and mitral positio
  • Z-3108-2017 · Feb 12, 2014 · Terminated
    On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in th

Other Heart-Valve, Mechanical devices

All Heart-Valve, Mechanical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page